It is impossible to have a conversation about maximizing one’s leadership effectiveness and bringing out the best in yourself and others without considering the profound impact and benefits of mentoring relationships. In my formative and adult years, I have served as both a “mentor” and the “mentee” in this informal and long-term, two-way relationship. Typically, […]
Leadership Series 2: Mentoring Matters Read More »
A study has revealed the protein responsible for causing pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer. The researchers, from the University of Texas MD Anderson Cancer Center, US, validated ubiquitin-specific protease 21 (UPS21) as a frequently amplified gene and a potential druggable target. “The USP family is the largest group of
New Target for Pancreatic Cancer Read More »
Ron DePinho, M.D., an internationally renowned physician-scientist and cancer researcher, has come to believe that the most effective way to fight cancer is to focus not just on groundbreaking research and therapies to cure the disease but on harnessing the power of what we already know to prevent it. “There’s enough knowledge of what causes
Stopping Cancer: Five Questions with Ron DePinho Read More »
It has been my privilege to serve in diverse leadership and advisory roles over the years for premier healthcare institutions and biopharmaceutical organizations. These roles include research laboratory head, academic executive appointments and founder, director and/or advisor for biotech and pharma, as well as non-profit foundations and faith-based institutions. In my own experience and interactions
Leadership Series 1: Striving for Excellence in Healthcare Leadership Read More »
A common genetic deficiency empowers glioblastoma to broadcast a molecular message to the wrong type of immune cell, summoning macrophages that protect and nurture the brain tumor instead of attacking it, researchers at The University of Texas MD Anderson Cancer Center report in Cancer Cell. The team’s work in mouse models of glioblastoma that lack
Study finds macrophages’ pathway to nurture PTEN-deficient glioblastoma Read More »
Health Organizations Applaud Leader Mitch McConnell And Senator Tim Kaine For Their Bill That Would Raise The Sales Age Of Tobacco Products To 21, Saying It ‘Will Help Remove Tobacco From High Schools,’ ‘Be Instrumental In Stemming The Epidemic Of Vaping,’ And Could ‘Save Hundreds Of Thousands Of Lives’ UNITE TO PREVENT CANCER Co-Founder Dr.
Tobacco 21: An Important Step Forward Read More »
As the father of three children and a physician, educator and scientist, I always make sure to impart my health and wellness knowledge to my children (currently 15, 16 and 18 years old) – doing everything possible to mitigate risk for disease later in life. When it comes to cancer, it is notable that up
Findings demonstrate how two cancer-related genes interact to spur metastasis and potentially enhance immune checkpoint blockade treatment MD Anderson News Release March 21, 2019 Researchers at The University of Texas MD Anderson Cancer Center revealed the common oncogene KRAS as a possible explanation for why many patients with metastatic colorectal cancer (CRC) do not respond
The year 2018 was a notable one for the cancer research community and our quest to prevent, detect and treat cancer. Fueled largely by our nation’s continued investment in basic and applied biomedical research, significant progress has occurred in areas of targeted and immune therapy as well as molecular diagnostics. Below is a ‘top ten’
2018 Top Ten Highlights Read More »
The U.S. Food and Drug Administration has issued a long awaited update to sunscreen rules aimed at strengthening regulations of over-the-counter sunscreens Thursday. Two of the 16 currently used main chemical ingredients in over-the-counter sunscreen products are considered safe, the FDA says, as part of a proposal here aimed at improving the safety and quality
FDA tightens regulation of over-the-counter sunscreen products Read More »
Sign up for the latest news and updates from Ron DePinho, MD
